Condition
Infraorbital Hollows
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
3 of 3 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04577898Not ApplicableCompletedPrimary
RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows
NCT07255261Not ApplicableRecruiting
Evaluation of Facial HA Dermal Fillers in Real-Life Conditions
NCT06749587Not ApplicableRecruitingPrimary
TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults
NCT04154930Not ApplicableCompletedPrimary
Restylane-L for Correction of Infraorbital Hollows
NCT00852241Phase 4CompletedPrimary
Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study
Showing all 5 trials